The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Pharmaceutical Safety Assessment Market During The 2026–2030 Period?
The pharmaceutical safety assessment market has seen significant growth in recent years. This market is anticipated to expand from $11.32 billion in 2025 to $12.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. The historical expansion of the market can be linked to the broadening of pharmaceutical R&D pipelines, increased regulatory oversight concerning drug safety, a rise in preclinical and clinical testing activities, greater adoption of in-vitro safety assessment methods, and the growing reliance on CRO-conducted safety studies.
The pharmaceutical safety assessment market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $16.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion during the forecast period is attributable to an increasing reliance on computational safety assessment, the broadening scope of personalized medicine development, a rising demand for faster regulatory approvals, the growing integration of AI in drug safety workflows, and increased post-market surveillance requirements. Key trends expected in the forecast period include the increasing use of AI-based toxicity prediction tools, the rising adoption of in-silico safety assessment models, the growing integration of real-time pharmacovigilance systems, the expansion of automated preclinical testing platforms, and an enhanced focus on regulatory-compliant safety analytics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp
What Important Drivers Are Powering The Pharmaceutical Safety Assessment Market Growth?
The expansion of clinical trials is anticipated to drive the growth of the pharmaceutical safety assessment market moving forward. Clinical trials represent research investigations conducted in humans to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or interventions. The rise in these trials is due to the increasing necessity for novel and effective treatments, as researchers and healthcare providers aim to develop therapies capable of better preventing, managing, or curing diseases. Clinical trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, establishing safe dosage ranges, and supplying essential data that regulatory authorities utilize to ensure medications are both effective and safe for public use. For instance, in September 2025, the National Library of Medicine (NLM), a US-based biomedical library, reported a total of 554,798 studies registered on ClinicalTrials.gov as of September 26, 2025. Therefore, the broadening of clinical trials is a key factor propelling the growth of the pharmaceutical safety assessment market.
Which Segment Divisions Form The Structure Of The Pharmaceutical Safety Assessment Market?
The pharmaceutical safety assessment market covered in this report is segmented –
1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
2) By Drug Type: Biological Drugs, Chemical Drugs
3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)
Subsegments:
1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies
What Trends Are Affecting The Growth Of The Pharmaceutical Safety Assessment Market?
Leading companies in the pharmaceutical safety assessment market are concentrating their efforts on developing AI-powered decision support tools, aimed at boosting the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is essentially a software system that uses artificial intelligence to analyze data, providing insights that facilitate faster and more precise decision-making. As an illustration, in April 2024, Charles River Laboratories, a US-based life sciences company, partnered with Deciphex, an Ireland-based company recognized for enhancing diagnostic precision and speed via AI-driven quality assurance, to launch the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to transform toxicologic pathology within pharmaceutical safety assessment. The platform leverages artificial intelligence to rapidly analyze complex preclinical pathology data, which helps in identifying potential safety risks sooner and reduces subjectivity in results. It features unique attributes such as an AI algorithm capable of detecting tissue abnormalities, a cloud-based system enabling global collaboration, and a scalable design that minimizes slide review time while concurrently improving data accuracy and consistency.
Which Firms Are Competing In The Pharmaceutical Safety Assessment Market?
Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.
Access The Complete Pharmaceutical Safety Assessment Market Report:
Which Region Leads The Pharmaceutical Safety Assessment Market By Size?
North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceutical Safety Assessment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company
Pharmaceutical Chemicals Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report
Pharmacovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model